Potent Induction Immunotherapy Promotes Long-Term Insulin Independence After Islet Transplantation in Type 1 Diabetes
Top Cited Papers
Open Access
- 11 April 2012
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 12 (6), 1576-1583
- https://doi.org/10.1111/j.1600-6143.2011.03977.x
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The calcineurin inhibitor tacrolimus allows the induction of functional CD4+CD25+ regulatory T cells by rabbit anti-thymocyte globulinsClinical and Experimental Immunology, 2010
- Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-CellsDiabetes, 2010
- Role of TNFα in Early Chemokine Production and Leukocyte Infiltration into Heart AllograftsAmerican Journal of Transplantation, 2009
- Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 yearsClinical Immunology, 2009
- Innate immunity and heat shock response in islet transplantationClinical and Experimental Immunology, 2009
- Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell TransplantationPLOS ONE, 2008
- Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cellsJCI Insight, 2008
- Recovery from diabetes in mice by β cell regenerationJCI Insight, 2007
- Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulinClinical and Experimental Immunology, 2007
- Islet cell failure in type 2 diabetesJCI Insight, 2006